These findings provide valuable insights into the potential mechanisms through which PDCD6 contributes to the onset and progression of hepatocellular carcinoma, suggesting its role as a significant molecular target in HCC research and therapy. The gene discussed is PDCD6; the disease is hepatocellular carcinoma.